Meitar represented Avaya, a business communications solutions provider, in its acquisition of Radvision, a Tel Aviv-based company developing HD and converged video conferencing solutions, for approximately $230 million in cash. The transaction is expected to be completed during the second quarter of 2012.
Meitar represented Covidien, a U.S. medical device manufacturer, in its acquisition of SuperDimension, an Israeli company with a cutting-edge technology for minimally-invasive surgical procedures on the lungs, for $300 million in cash, with future earn out payments possible. The transaction is expected to be completed during the second quarter of 2012.
Meitar represented Singapore Telecom, Southeast Asia’s largest telecom company, in its acquisition of Amobee, a mobile advertising company, for approximately $320 million in cash. The transaction is expected to be completed during the second quarter of 2012.
Meitar acted as local counsel for Cisco in its intended acquisition of NDS Group, a leading provider of video software and content security solutions for approximately $5 billion. The transaction is expected to be completed during the second half of 2012.
Meitar represented Objet, an Israel-based manufacturer of 3D printers, in a contemplated IPO on NASDAQ, which in its advanced stages was deferred, in a dual-tracking process, in favor of entering into an all-stock merger of equals with Stratasys, a Delaware corporation (NASDAQ:SSYS). Under this innovative structure, the shares of the publicly traded Stratasys will be exchanged for shares in the currently privately-held Objet. At closing, Objet will simultaneously become the parent company of the merged entities and, for the first time, a publicly traded company on NASDAQ.
Meitar represented Covidien, a U.S. medical device manufacturer, in its acquisition of Oridion Systems Ltd., an Israeli company and a global leader in capnography monitoring, for $346 million in cash. The transaction is expected to be completed during the second quarter of 2012.
